- Home
- KEX vs AXSM Comparison
KEX vs AXSM Comparison
Compare KEX & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KEX
- AXSM
- Stock Information
- Founded
- KEX 1921
- AXSM 2012
- Country
- KEX United States
- AXSM United States
- Employees
- KEX N/A
- AXSM N/A
- Industry
- KEX Marine Transportation
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- KEX Consumer Discretionary
- AXSM Health Care
- Exchange
- KEX Nasdaq
- AXSM Nasdaq
- Market Cap
- KEX 5.2B
- AXSM 4.8B
- IPO Year
- KEX N/A
- AXSM 2015
- Fundamental
- Price
- KEX $95.33
- AXSM $104.46
- Analyst Decision
- KEX Strong Buy
- AXSM Strong Buy
- Analyst Count
- KEX 3
- AXSM 15
- Target Price
- KEX $128.00
- AXSM $171.00
- AVG Volume (30 Days)
- KEX 645.7K
- AXSM 912.2K
- Earning Date
- KEX 05-01-2025
- AXSM 05-05-2025
- Dividend Yield
- KEX N/A
- AXSM N/A
- EPS Growth
- KEX 32.06
- AXSM N/A
- EPS
- KEX 4.91
- AXSM N/A
- Revenue
- KEX $3,265,876,000.00
- AXSM $385,693,000.00
- Revenue This Year
- KEX $6.07
- AXSM $63.85
- Revenue Next Year
- KEX $5.51
- AXSM $63.93
- P/E Ratio
- KEX $19.41
- AXSM N/A
- Revenue Growth
- KEX 5.64
- AXSM 42.53
- 52 Week Low
- KEX $83.94
- AXSM $64.11
- 52 Week High
- KEX $132.21
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- KEX 46.41
- AXSM 41.94
- Support Level
- KEX $93.14
- AXSM $86.99
- Resistance Level
- KEX $98.40
- AXSM $103.75
- Average True Range (ATR)
- KEX 4.63
- AXSM 5.84
- MACD
- KEX 0.16
- AXSM -0.01
- Stochastic Oscillator
- KEX 57.24
- AXSM 56.74
About KEX Kirby Corporation
Kirby Corp is a domestic tank barge operator, transporting bulk liquid products throughout three United States coasts. The Company transports petrochemicals, liquid cargoes, inland waterway systems, and dry bulk cargoes. The Company conducts operations in two reportable business segments: The Marine transportation segment which provides marine transportation services, operating tank barges and towing vessels transporting bulk liquid products, and the Distribution and services segment, which provides after-market service, and genuine replacement parts for engines, transmissions, reduction gears, and power generation equipment used in oil and gas and commercial and industrial applications. The company's revenue is generated from the Marine Transportation segment.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.